Apollo Hospitals Enterprise Ltd., Dr. Lal Path Labs Ltd., Hindustan Unilever Ltd., Hindustan Petroleum Corp., and NBCC (India) Ltd. are among stocks with ‘buy’ calls from analysts this Friday.
HDFC Securities Senior Technical & Derivative Analyst Vinay Rajani, Adlytick.in Founder and Multi Asset Research Analyst Aditya Arora, and Religare Broking Research Special Vice President Ajit Mishra have shared their views on the above-mentioned scrips with NDTV Profit.
Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Ltd. has a ‘buy’ recommendation from HDFC Securities’ Rajani. The target price for the stock is Rs 6,840.85 apiece, which implied a 2.33% upside from Wednesday’s closing price. The stop loss for the stock is Rs 6,720 apiece.
Out of 29 analysts tracking the company, 26 maintain a ‘buy’ rating, two recommend a ‘hold’ and one suggests to ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 13.4%.
Dr. Lal Path Labs
Dr. Lal Path Labs Ltd. has a ‘buy’ recommendation from Adlytick.in Founder Aditya Arora. The target price is Rs 2,830, which implied a 6.79% upside from Wednesday’s closing price. The stop loss for the stock is Rs 2,500 apiece.
Out of 27 analysts tracking the company, 17 maintain a ‘buy’ rating, two recommend a ‘hold’ and eight suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 21.9%.
HUL
Hindustan Unilever Ltd. got a ‘buy’ from Rajani. The target price for the stock is Rs 2,425, which implied a 3.24% upside from Wednesday’s closing price. The stop loss for the stock was at Rs 2,300.
Out of 44 analysts tracking the company, 28 maintain a ‘buy’ rating, 13 recommend a ‘hold’ and three suggest ‘sell’, according to Bloomberg data. The average 12-month analysts’ consensus price target implies an upside of 11.1%.
Hindustan Petroleum Corp.
Hindustan Petroleum Corp. got a ‘buy’ rating from Religare Broking’s Ajit Mishra. The target price is Rs 395, which implied a 4.14% upside from Wednesday’s close. The stop loss is Rs 530 apiece.
Out of 34 analysts tracking the company, 22 maintain a ‘buy’ rating, five recommend a ‘hold’ and seven suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 8.3%.
NBCC (India)
Adlytick.in’s Arora recommended a ‘buy’ for NBCC (India) Ltd. The target price for the stock is Rs 92.50, which implied 6.32% upside from Wednesday’s closing price. The stop loss for the stock is Rs 81.50 apiece.
Out of three analysts tracking the company, two maintain a ‘buy’ rating, and one suggests ‘sell’, according to Bloomberg data. The average 12-month analysts’ consensus price target implies an upside of 36.8%.
. Read more on Markets by NDTV Profit.These stocks has a ‘buy’ call from analysts this Friday. Read MoreMarkets, Business, Notifications
NDTV Profit
